Skip Navigation

JNCI Journal of the National Cancer Institute 2003 95(10):4E; doi:10.1093/jnci/95.10.E4
© 2003 by Oxford University Press
This Article
Right arrow Full Text Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Request Permissions
Google Scholar
Right arrow Articles by Stram, D. O.
Right arrow Articles by Wu, A. H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Stram, D. O.
Right arrow Articles by Wu, A. H.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Journal of the National Cancer Institute, Vol. 95, No. 10, E4, May 21, 2003
© 2003 Oxford University Press

ONLINE PERSPECTIVE

CORRESPONDENCE

Re: {beta}-Carotene and Lung Cancer: A Lesson for Future Chemoprevention Investigations?

Daniel O. Stram, Anna H. Wu

Affiliation of authors: Department of Preventive Medicine, Keck School of Medicine, University of Southern California, Los Angeles, CA.

Correspondence to: Daniel Stram, Ph.D., Department of Preventive Medicine, Keck School of Medicine, University of Southern California, Los Angeles, CA 90033 (e-mail: stram@usc.edu).

The first 10% of the full text of this article appears below.

Peter Greenwald’s review (1) of the issues surrounding the {alpha}-Tocopherol, {beta}-Carotene Cancer Prevention (ATBC) Study and {beta}-Carotene and the Retinol Efficacy Trial (CARET) mentions a number of possible reasons why the results of these trials . . . [Full Text of this Article]


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?